Evidence of overtesting for vitamin D in Australia: An analysis of 4.5 years of Medicare Benefits Schedule (MBS) data

BMJ Open

Volumn 3, Issue 6, 2013, Pages

  Bilinski, Kellie ^a,b   Boyages, Steve ^b  

^a WESTMEAD HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D;

ARTICLE; AUSTRALIA; BLOOD CELL COUNT; BONE DENSITOMETRY; DIAGNOSTIC TEST; GENERAL PRACTITIONER; HEALTH CARE COST; HUMAN; MEDICAL SPECIALIST; MEDICARE;

EID: 84880402398     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2013-002955     Document Type: Article

References (39)

1. Moynihan R, Doust J, Henry D. Preventing overdiagnosis: how to stop harming the healthy. BMJ 2012;344:e3502.
2. Van der Mei IA, Ponsonby AL, Engelsen O, et al. The high prevalence of vitamin D insufficiency across Australian populations is only partly explained by season and latitude. Environ Health Perspect 2007;115:1132-9. (Pubitemid 351802343)
3. Boyages S, Bilinski K. Seasonal reduction in vitamin D level persists into spring in NSW Australia: implications for monitoring and replacement therapy. Clin Endocrinol (Oxf) 2012;77:515-23.
4. Bilinski KL, Boyages SC. The rising cost of vitamin D testing in Australia: time to establish guidelines for testing. Med J Aust 2012;197:90.
5. Mittelstaedt M. Ontario considers curbing vitamin D testing. The Globe and Mail 2010 October 19, 2010 (accessed 29 May 2012).
6. Sattar N, Welsh P, Panarelli M, et al. Increasing requests for vitamin D measurement: costly, confusing, and without credibility. Lancet 2012;379:95-6.
7. Bouillon R, Eisman J, Garabedian M, et al. Action spectrum for the production of previtamin D3 in human skin. Vienna: CIE, 2006.
8. Working group of the Australian and New Zealand Bone and Mineral Society ESoAaOA. Vitamin D and adult bone health in Australia and New Zealand: a position statement. Med J Aust 2005;182:281-5.
9. Heijboer AC, Blankenstein MA, Kema IP, et al. Accuracy of 6 routine 25-hydroxyvitamin D assays: influence of vitamin D binding protein concentration. Clin Chem 2012;58:543-8.
10. Holick MF. High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc 2006;81:353-73. (Pubitemid 43334631)
11. Boyages S, Bilinski K. Seasonal reduction in vitamin D level persists into spring in NSW Australia: implications for monitoring and replacement therapy. Clin Endocrinol (Oxf) 2012;77:515-23.
12. Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2011;96:1911-30.
13. Holick MF. Optimal vitamin D status for the prevention and treatment of osteoporosis. Drugs Aging 2007;24:1017-29. (Pubitemid 350145410)
14. Grant WB. Ecological studies of the UVB-vitamin D-cancer hypothesis. Anticancer Res 2012;32:223-36.
15. Souberbielle JC, Body JJ, Lappe JM, et al. Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: recommendations for clinical practice. Autoimmun Rev 2010;9:709-15.
16. Anderson JL, May HT, Horne BD, et al. Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. Am J Cardiol 2010;106:963-8.
17. Schottker B, Haug U, Schomburg L, et al. Strong associations of 25-hydroxyvitamin D concentrations with all-cause, cardiovascular, cancer, and respiratory disease mortality in a large cohort study. Am J Clin Nutr 2013;97:782-93.
18. Afzal S, Bojesen SE, Nordestgaard BG. Low 25-hydroxyvitamin D and risk of type 2 diabetes: a prospective cohort study and metaanalysis. Clin Chem 2013;59:381-91.
19. Schottker B, Ball D, Gellert C, et al. Serum 25-hydroxyvitamin D levels and overall mortality. A systematic review and meta-analysis of prospective cohort studies. Ageing Res Rev 2012. Published Online First 2012. doi: 10.1016/j.arr.2012.02.004
20. Wei SQ, Qi HP, Luo ZC, et al. Maternal vitamin D status and adverse pregnancy outcomes: a systematic review and metaanalysis. J Matern Fetal Neonatal Med 2013;26:889-99.
21. Biesalski HK, Aggett PJ, Anton R, et al. 26th Hohenheim Consensus Conference, September 11, 2010 Scientific substantiation of health claims: evidence-based nutrition. Nutrition 2011;27(Suppl 10):S1-20.
22. Singh RJ. Are clinical laboratories prepared for accurate testing of 25-hydroxy vitamin D? Clin Chem 2008;54:221-3. (Pubitemid 351182624)
23. Rizzoli R, Boonen S, Brandi ML, et al. Vitamin D supplementation in elderly or postmenopausal women: a 2013 update of the 2008 recommendations from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Curr Med Res Opin 2013;29:305-13.
24. Mata-Granados JM, Cuenca-Acevedo JR, de Castro MD Luque, et al. Vitamin D insufficiency together with high serum levels of vitamin A increases the risk for osteoporosis in postmenopausal women. Arch Osteoporos 2013;8:124.
25. Boyages S, Bilinski K. The vitamin D paradox: bone density testing in females aged 45 to 74 did not increase over a ten year period despite a marked increase in testing for vitamin D. J Endocrinol Invest 2013. Published Online First 2013. doi: 10.3275/8922
26. Lubarsky DA, Glass PSA, Ginsberg B, et al. The successful implementation of Pharmaceutical Practice Guidelines: analysis of associated outcomes and cost savings. Anesthesiology 1997;86:1145-60. (Pubitemid 27208913)
27. Cummings SR, Nevitt MC, Browner WS, et al. Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med 1995;332:767-73.
28. Nowson CA, McGrath JJ, Ebeling PR, et al. Vitamin D and health in adults in Australia and New Zealand: a position statement. Med J Aust 2012;196:686-7.
29. Heaney RP, Davies KM, Chen TC, et al. Human serum 25- hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr 2003;77:204-10. (Pubitemid 36015393)
30. Health Quality Ontario. Clinical utility of vitamin D testing: an evidence-based analysis. Ontario Health Technol Assess Ser 2010;10:1-93.
31. Garland CF, French CB, Baggerly LL, et al. Vitamin D supplement doses and serum 25-hydroxyvitamin D in the range associated with cancer prevention. Anticancer Res 2011;31:607-11.
32. Grant WB, Schwalfenberg GK, Genuis SJ, et al. An estimate of the economic burden and premature deaths due to vitamin D deficiency in Canada. Mol Nutr Food Res 2010;54:1172-81.
33. Grant WB, Garland CF, Holick MF. Comparisons of estimated economic burdens due to insufficient solar ultraviolet irradiance and vitamin D and excess solar UV irradiance for the United States. Photochem Photobiol 2005;81:1276-86. (Pubitemid 43035836)
34. GrantWB. An estimate of the global reduction in mortality rates through doubling vitamin D levels. Eur J Clin Nutr 2011;65:1016-26.
35. Bailey BA, Manning T, Peiris AN. Vitamin D testing patterns among six Veterans Medical Centers in the southeastern United States: links with medical costs. Mil Med 2012;177:70-6.
36. Service NP. Appropriate vitamin D testing. 2011. http://www.nps.org. au/-data/assets/pdf-file/0016/112237/MBS-sample-feedback-letter.pdf (accessed 20 May 2012).
37. Ebeling PE, Eisman J. Recommendations from the Vitamin D and Calcium Forum. Med Today 2005;6.
38. Group CE. Vitamin D guidance. London: Clinical Effectiveness Group, Centre for Health Sciences, Institute of Health Sciences Education, 2011.
39. NHMRC. Nutrient reference values for Australia and New Zealand including recommended dietary intakes: Australian Government Department of Health and Ageing, National Health and Medical Research Council, 2005.